| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
Pharvaris N.V (NASDAQ: PHVS)
PHVS Technical Analysis
4
| As on 9th Jun 2023 PHVS STOCK Price closed @ 11.33 and we RECOMMEND Sell for LONG-TERM with Stoploss of 15.14 & Strong Sell for SHORT-TERM with Stoploss of 17.16 we also expect STOCK to react on Following IMPORTANT LEVELS. |
PHVSSTOCK Price
| Open | 9.00 | Change | Price | % |
| High | 11.65 | 1 Day | 2.33 | 25.89 |
| Low | 8.56 | 1 Week | 2.73 | 31.74 |
| Close | 11.33 | 1 Month | 2.32 | 25.75 |
| Volume | 30189 | 1 Year | -4.17 | -26.90 |
| 52 Week High 27.50 | 52 Week Low 1.98 | ||||
NASDAQ USA Most Active Stocks
| TSLA | 244.40 | 4.06% |
| TTOO | 0.07 | -12.50% |
| SOFI | 8.18 | 0.74% |
| FFIE | 0.33 | 6.45% |
| PONO | 1.72 | 2.38% |
| AMD | 124.92 | 3.20% |
| IDEX | 0.06 | 0.00% |
| NKLA | 0.70 | 14.75% |
| AMZN | 123.43 | -0.66% |
| AAPL | 180.96 | 0.22% |
NASDAQ USA Top Gainers Stocks
NASDAQ USA Top Losers Stocks
| PHVS Daily Charts |
PHVS Intraday Charts |
Whats New @ Bazaartrend |
PHVS Free Analysis |
|
|
PHVS Important Levels Intraday
| RESISTANCE | 17.28 |
| RESISTANCE | 15.37 |
| RESISTANCE | 14.19 |
| RESISTANCE | 13.01 |
| SUPPORT | 9.65 |
| SUPPORT | 8.47 |
| SUPPORT | 7.29 |
| SUPPORT | 5.38 |
PHVS Forecast May 2024
| 4th UP Forecast | 22.1 |
| 3rd UP Forecast | 18.65 |
| 2nd UP Forecast | 16.51 |
| 1st UP Forecast | 14.38 |
| 1st DOWN Forecast | 8.28 |
| 2nd DOWN Forecast | 6.15 |
| 3rd DOWN Forecast | 4.01 |
| 4th DOWN Forecast | 0.56 |
PHVS Weekly Forecast
| 4th UP Forecast | 15.80 |
| 3rd UP Forecast | 14.37 |
| 2nd UP Forecast | 13.48 |
| 1st UP Forecast | 12.59 |
| 1st DOWN Forecast | 10.07 |
| 2nd DOWN Forecast | 9.18 |
| 3rd DOWN Forecast | 8.29 |
| 4th DOWN Forecast | 6.86 |
PHVS Forecast2024
| 4th UP Forecast | 60.91 |
| 3rd UP Forecast | 45.01 |
| 2nd UP Forecast | 35.18 |
| 1st UP Forecast | 25.35 |
| 1st DOWN Forecast | -2.69 |
| 2nd DOWN Forecast | -12.52 |
| 3rd DOWN Forecast | -22.35 |
| 4th DOWN Forecast | -38.25 |
Pharvaris N.V ( NASDAQ USA Symbol : PHVS )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
PHVS Business Profile
Pharvaris N.V., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapies for rare diseases. The company develops PHA121, a small molecule bradykinin B2-receptor antagonist that is in Phase II clinical trial for the treatment of hereditary angioedema (HAE). It also develops PHVS416, an on-demand, rapid exposure soft capsule for patients suffering from acute HAE attacks; and PHVS719, a prophylactic extended-release tablet for HAE patients. It operates in the Netherlands, Switzerland, and the United States. The company was incorporated in 2015 and is headquartered in Leiden, the Netherlands. Address: J.H. Oortweg 21, Leiden, Netherlands, 2333 CH
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service